ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) Stock Fundamental Analysis
USA - NYSE:AQNB - US0158578080
25.36 USD
+0.01 (+0.04%)
AQNB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 25 industry peers in the Multi-Utilities industry. AQNB may be in some trouble as it scores bad on both profitability and health. AQNB is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
AQNB had positive earnings in the past year.
AQNB had a positive operating cash flow in the past year.
In multiple years AQNB reported negative net income over the last 5 years.
AQNB had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
AQNB has a Return On Assets of -10.09%. This is amonst the worse of the industry: AQNB underperforms 96.00% of its industry peers.
With a Return On Equity value of -29.51%, AQNB is not doing good in the industry: 96.00% of the companies in the same industry are doing better.
AQNB's Return On Invested Capital of 3.00% is on the low side compared to the rest of the industry. AQNB is outperformed by 88.00% of its industry peers.
AQNB had an Average Return On Invested Capital over the past 3 years of 2.36%. This is in line with the industry average of 3.82%.
The 3 year average ROIC (2.36%) for AQNB is below the current ROIC(3.00%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.09% | ||
| ROE | -29.51% | ||
| ROIC | 3% |
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
1.3 Margins
AQNB has a Operating Margin (20.38%) which is comparable to the rest of the industry.
AQNB's Operating Margin has declined in the last couple of years.
The Gross Margin of AQNB (74.06%) is better than 72.00% of its industry peers.
AQNB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.38% | ||
| PM (TTM) | N/A | ||
| GM | 74.06% |
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AQNB is destroying value.
The number of shares outstanding for AQNB has been increased compared to 1 year ago.
AQNB has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AQNB has an improved debt to assets ratio.
2.2 Solvency
AQNB has an Altman-Z score of 1.30. This is a bad value and indicates that AQNB is not financially healthy and even has some risk of bankruptcy.
With an excellent Altman-Z score value of 1.30, AQNB belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.
AQNB has a Debt/Equity ratio of 1.29. This is a high value indicating a heavy dependency on external financing.
AQNB has a better Debt to Equity ratio (1.29) than 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.29 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.3 |
ROIC/WACC0.42
WACC7.1%
2.3 Liquidity
AQNB has a Current Ratio of 1.09. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
AQNB has a Current ratio of 1.09. This is amongst the best in the industry. AQNB outperforms 88.00% of its industry peers.
AQNB has a Quick Ratio of 1.09. This is a bad value and indicates that AQNB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.90, AQNB belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 0.9 |
3. Growth
3.1 Past
The earnings per share for AQNB have decreased strongly by -36.00% in the last year.
The earnings per share for AQNB have been decreasing by -10.38% on average. This is quite bad
Looking at the last year, AQNB shows a very negative growth in Revenue. The Revenue has decreased by -25.45% in the last year.
AQNB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.38% yearly.
EPS 1Y (TTM)-36%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%-55.56%
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-11.83%
3.2 Future
The Earnings Per Share is expected to grow by 6.99% on average over the next years.
The Revenue is expected to grow by 2.30% on average over the next years.
EPS Next Y-15.38%
EPS Next 2Y-0.64%
EPS Next 3Y5.49%
EPS Next 5Y6.99%
Revenue Next Year-11.06%
Revenue Next 2Y-4.03%
Revenue Next 3Y-1.05%
Revenue Next 5Y2.3%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 79.25, which means the current valuation is very expensive for AQNB.
Based on the Price/Earnings ratio, AQNB is valued expensively inside the industry as 92.00% of the companies are valued cheaper.
The average S&P500 Price/Earnings ratio is at 27.27. AQNB is valued rather expensively when compared to this.
AQNB is valuated quite expensively with a Price/Forward Earnings ratio of 69.42.
96.00% of the companies in the same industry are cheaper than AQNB, based on the Price/Forward Earnings ratio.
AQNB is valuated expensively when we compare the Price/Forward Earnings ratio to 22.77, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 79.25 | ||
| Fwd PE | 69.42 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 28.7 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.64%
EPS Next 3Y5.49%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.72%, AQNB is a good candidate for dividend investing.
AQNB's Dividend Yield is rather good when compared to the industry average which is at 3.64. AQNB pays more dividend than 92.00% of the companies in the same industry.
AQNB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.72% |
5.2 History
The dividend of AQNB has a limited annual growth rate of 0.06%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
AQNB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
AQNB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-17.76%
EPS Next 2Y-0.64%
EPS Next 3Y5.49%
ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079
NYSE:AQNB (9/16/2025, 4:15:00 PM)
25.36
+0.01 (+0.04%)
Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)
Earnings (Next)
Inst Owners72.96%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.48B
Analysts52.86
Price Target22.5 (-11.28%)
Short Float %0%
Short Ratio0.74
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.72% |
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-17.76%
Div Incr Years1
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.74%
Min EPS beat(2)-0.69%
Max EPS beat(2)42.17%
EPS beat(4)1
Avg EPS beat(4)0.15%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)3
Avg EPS beat(8)0.22%
EPS beat(12)4
Avg EPS beat(12)-3.83%
EPS beat(16)5
Avg EPS beat(16)-3.04%
Revenue beat(2)2
Avg Revenue beat(2)3.06%
Min Revenue beat(2)0.82%
Max Revenue beat(2)5.31%
Revenue beat(4)2
Avg Revenue beat(4)0.36%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-2.11%
Revenue beat(12)7
Avg Revenue beat(12)0.07%
Revenue beat(16)10
Avg Revenue beat(16)1.41%
PT rev (1m)7.13%
PT rev (3m)10.02%
EPS NQ rev (1m)-0.82%
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.98%
EPS NY rev (3m)5.98%
Revenue NQ rev (1m)0.95%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.65%
Revenue NY rev (3m)-1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 79.25 | ||
| Fwd PE | 69.42 | ||
| P/S | 8.19 | ||
| P/FCF | N/A | ||
| P/OCF | 44.15 | ||
| P/B | 4.16 | ||
| P/tB | 5.91 | ||
| EV/EBITDA | 28.7 |
EPS(TTM)0.32
EY1.26%
EPS(NY)0.37
Fwd EY1.44%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.57
OCFY2.27%
SpS3.1
BVpS6.1
TBVpS4.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.09% | ||
| ROE | -29.51% | ||
| ROCE | 3.8% | ||
| ROIC | 3% | ||
| ROICexc | 3.01% | ||
| ROICexgc | 3.38% | ||
| OM | 20.38% | ||
| PM (TTM) | N/A | ||
| GM | 74.06% | ||
| FCFM | N/A |
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexcg growth 3Y4.3%
ROICexcg growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.29 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 6.71 | ||
| Cap/Depr | 209.43% | ||
| Cap/Sales | 36.33% | ||
| Interest Coverage | 1.25 | ||
| Cash Conversion | 49.18% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | 1.3 |
F-Score4
WACC7.1%
ROIC/WACC0.42
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%-55.56%
EPS Next Y-15.38%
EPS Next 2Y-0.64%
EPS Next 3Y5.49%
EPS Next 5Y6.99%
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-11.83%
Revenue Next Year-11.06%
Revenue Next 2Y-4.03%
Revenue Next 3Y-1.05%
Revenue Next 5Y2.3%
EBIT growth 1Y-22.44%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year44.64%
EBIT Next 3Y17.99%
EBIT Next 5YN/A
FCF growth 1Y-33.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.88%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%